EARNINGS AND TRADING: Castelnau swings to profit; hVIVO sees growth
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Price | 16.625p on 17-04-2025 | at 09:08:30
---|---|
Change | 0.00p 0% |
Buy | 17.00p |
Sell | 16.25p |
Buy / Sell HVO Shares |
Last Trade: | Sell 7,257.00 at 16.30p |
Day's Volume: | 131,191 |
Last Close: | 16.625p |
Open: | 16.625p |
ISIN: | GB00B9275X97 |
Day's Range | 16.625p - 16.625p |
52wk Range: | 12.60p - 30.60p |
Market Capitalisation: | £114m |
VWAP: | 16.49572p |
Shares in Issue: | 687m |
Sector: Health Care and Related Services
Listed In: FTSE AIM 100, FTSE AIM All-Share,
hVIVO (HVO) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 7,257 | 16.30p | Ordinary |
10:08:29 - 17-Apr-25 |
Buy* | 5,835 | 16.75p | Ordinary |
10:08:22 - 17-Apr-25 |
Sell* | 20,000 | 16.30p | Ordinary |
10:08:02 - 17-Apr-25 |
Sell* | 15,000 | 16.5013p | Ordinary |
10:07:00 - 17-Apr-25 |
Unknown* | 3,515 | 16.625p | Negotiated Trade |
09:51:09 - 17-Apr-25 |
Unknown* | 3,515 | 16.625p | Negotiated Trade |
09:51:00 - 17-Apr-25 |
Sell* | 18 | 16.60p | Ordinary |
09:43:26 - 17-Apr-25 |
Sell* | 15,060 | 16.60p | Ordinary |
09:40:41 - 17-Apr-25 |
Sell* | 1,807 | 16.60p | Ordinary |
09:40:21 - 17-Apr-25 |
Sell* | 15,105 | 16.55p | Ordinary |
09:40:19 - 17-Apr-25 |
hVIVO (HVO) Regulatory News |
||
Date | Source | Headline |
---|---|---|
10th Apr 2025 7:05 am | RNS | Exercise of Options |
10th Apr 2025 7:00 am | RNS | Final results |
26th Mar 2025 1:51 pm | RNS | AIM Rule 17 and Schedule 2(g) Update |
21st Mar 2025 7:00 am | RNS | Notice of Results |
7th Mar 2025 7:00 am | RNS | Director/PDMR Shareholding |
27th Feb 2025 7:00 am | RNS | Acquisition of Cryostore for up to £3.2m |
17th Feb 2025 7:00 am | RNS | £2m hMPV characterisation study contract |
5th Feb 2025 7:00 am | RNS-R | Shionogi reports positive RSV trial results |
3rd Feb 2025 7:00 am | RNS | RSV contract signed with Inhalon Biopharma |
31st Jan 2025 1:24 pm | RNS | Holding(s) in Company |